Key facts
- This page summarizes Cameron Dovi Smith's Form 4 filing for MedMen Enterprises, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 20 Sep 2022, 19:13.
Cameron Dovi Smith - 19 Apr 2022 Form 4 Insider Report for MedMen Enterprises, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 19 Apr 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 Sep 2022, 19:13:24 UTC
- Prior SEC filing
- 13 Dec 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Cameron Dovi Smith
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Cameron Dovi Smith filed Form 4 for MedMen Enterprises, Inc. on 20 Sep 2022.
Change
- Previous filing in this sequence was filed on 13 Dec 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MMNFF
transaction
Class B Subordinate Voting Shares
Award
- Transaction value
- $0
- Shares
- +143,449
- Change %
- +17%
- Price
- $0.000000
- Shares after
- 984,022
- Date
- 19 Apr 2022
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Class B Subordinate Voting Shares granted as part of Reporting Person's annual compensation for service as a director of Issuer.